Rotator Cuff Tears Clinical Trial
— SiDOfficial title:
Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
NCT number | NCT05868148 |
Other study ID # | UE-02-2021 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | October 20, 2023 |
Est. completion date | December 2035 |
The goal of the Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study is to collect safety and performance data on the commercially available Shoulder iD™ Primary Reversed Glenoid device. The study will learn about standard device use in adult patients who have a functional deltoid muscle and massive and non-repairable rotator cuff tear. The main questions it aims to answer are: - What is the average improvement in patient-reported shoulder function after 2 years when compared to before the surgery, and - What is the rate of surgical revisions needed over a 10 year period Patients will be asked to will be asked to regularly attend their check-up visits with their surgeon (including having x-rays or CT images taken to check their shoulder and implant), to complete questionnaires to report how their shoulder is doing, and to tell their surgeon when they notice any changes.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | December 2035 |
Est. primary completion date | December 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - 18 years or older at the time of the informed consent or non-opposition (when applicable). - Informed and willing to sign an informed consent form approved by IRB or EC (when applicable). - Willing and able to comply with the requirements of the study protocol. - Considered a candidate for shoulder arthroplasty using a study device. - Meets indications for use requirements or other local, regional, or geographic specific regulatory requirements Exclusion Criteria: - Patients who are not able to comply with the study procedures based on the judgment of the assessor (e.g., cannot comprehend study questions, inability to keep scheduled assessment times). - Patient belongs to a vulnerable group of patients, including minor patients, those unable to decide for themselves to participate or needing a Legally Authorized Representative (LAR), or others who could be subject to coercion (patients who may not be acting on their own initiative) (referred to as a "vulnerable subject" in section 3.44 of the ISO 14155:2020). - Active local or systemic infection, sepsis, or osteomyelitis - Poor bone quality, where there could be considerable migration of the prothesis and/or a chance of fracture of the humerus or glenoid (reassessed at time of surgery) - Significant injury to the brachial plexus - Inadequate bone stock in the proximal humerus or glenoid fossa for supporting the device components - Neuromuscular disease (e.g., joint neuropathy) Known allergy to one of the product materials - Metabolic disorders which may impair bone formation |
Country | Name | City | State |
---|---|---|---|
United States | Coastal Orthopedics | Bradenton | Florida |
United States | Jameson Crane Sports Medicine Institute OSU | Columbus | Ohio |
United States | UT Health Science center - Houston | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
Stryker Trauma GmbH |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Performance: change in functional ability of the treated shoulder | The average change in functional ability as measured by the American Shoulder and Elbow Surgeons (ASES) score. ASES is an absolute score ranging from 0 to 100 where a higher score indicates better shoulder function. | from baseline to 24 months | |
Primary | Safety: Revision rate and device survivorship | The cumulative incidence of device revisions and reoperations | from date of inclusion until date of study exit (study completion or early termination for any cause), assessed up to 10 years | |
Secondary | Performance: change in level of pain and ability to carry out normal daily activities of the patient | Assessed via the Constant-Murley Shoulder score collected at baseline, years 1, 2, 5 and 10 and any other standard collection timepoint. In this score, 35 points are allocated for subjective assessments of pain and activities of daily living and 65 points are available for objective measures of rage of movement and shoulder strength. A score of 100 is a healthy shoulder. | from date of inclusion until date of study exit (study completion or early termination for any cause), assessed up to 10 years | |
Secondary | Performance: change in patient self-assessment of current status of their treated shoulder | Assessed via the Single Assessment Numeric Evaluation (SANE) score collected from patients via ePRO at baseline, 3 months, and annually. The rating is from 0% to 100% with 100% being normal. | from date of inclusion until date of study exit (study completion or early termination for any cause), assessed up to 10 years | |
Secondary | Performance: change in patient self-rated quality of life | Assessed via EQ-5D-5L Five Dimensions Quality of Life measurement general health questionnaire collected from patients via ePRO at baseline, 3 months and annually. Each dimension is measured on 5 levels from 1 being no problems to 5 being extreme problems. | from date of inclusion until date of study exit (study completion or early termination for any cause), assessed up to 10 years | |
Secondary | Performance: change in patient satisfaction with their shoulder | Satisfaction rating collected from patients via ePRO at baseline, 3 months and annually. Rating options are: Very Satisfied, Satisfied, Dissatisfied, and Very Dissatisfied. | from date of inclusion until date of study exit (study completion or early termination for any cause), assessed up to 10 years | |
Secondary | Safety: Adverse Event rate and assessments | Cumulative incidence of procedure and/or device related events (ADE, AESI, SAE, SADE) | from date of treatment until date of study exit (study completion or early termination for any cause), assessed up to 10 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04974242 -
Physiotherapy for Patients Awaiting Rotator Cuff Repair
|
N/A | |
Recruiting |
NCT06055478 -
Effect of Suprascapular Nerve Block and Axillary Nerve Block After Arthroscopic Rotator Cuff Repair
|
N/A | |
Completed |
NCT04552925 -
Exercises With Electromyographic Biofeedback in Conservative Treatment of Massive Rotator Cuff Tears
|
N/A | |
Not yet recruiting |
NCT06032416 -
DenCT Shoulder Bone Quality Evaluation
|
N/A | |
Not yet recruiting |
NCT04047745 -
Post-operative Exparel Study Following Rotator Cuff Repair
|
N/A | |
Completed |
NCT01029574 -
Platelet Rich Plasma on Rotator Cuff Repair
|
Phase 3 | |
Not yet recruiting |
NCT05817578 -
Profiling the RCRSP Patient: a Pain Phenotype Classification Algorithm
|
||
Not yet recruiting |
NCT05670080 -
Does MI Have a Therapeutic Role in Arthroscopic Rotator Cuff Repair?
|
N/A | |
Suspended |
NCT04421417 -
The Effect of Microfracture Procedure on Rotator Cuff Tendon Healing
|
N/A | |
Recruiting |
NCT06156423 -
Investigation of the Effect of Motor Control Exercises in Patients Undergoing Rotator Cuff Surgery
|
N/A | |
Completed |
NCT06145815 -
Machine Learning Predictive Model for Rotator Cuff Repair Failure
|
||
Not yet recruiting |
NCT05009498 -
Vitamin D3 Supplementation for Vitamin D Deficiency in Rotator Cuff Repair Surgery
|
N/A | |
Terminated |
NCT04855968 -
The Effect of Mindfulness/Meditation on Post-operative Pain and Opioid Consumption
|
N/A | |
Completed |
NCT04594408 -
Tranexamic Acid to Improve Arthroscopic Visualization in Shoulder Surgery
|
Phase 4 | |
Not yet recruiting |
NCT04538001 -
Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear
|
N/A | |
Completed |
NCT04710966 -
Comparison Between Arthroscopic Debridement and Repair for Partial-thickness Rotator Cuff Tears
|
N/A | |
Recruiting |
NCT06192459 -
Effect of the Muscle Strength and Range of Motion Training for Post-platelet Rich Plasma Injection in People With Rotator Cuff Partial Tear
|
N/A | |
Recruiting |
NCT05925881 -
Lower Trapezius Transfer vs Bridging Reconstruction
|
N/A | |
Recruiting |
NCT05988541 -
Rotator Cuff Integrity and Clinical Outcomes 5 Years After Repair.
|
N/A | |
Not yet recruiting |
NCT04584476 -
Superior Capsular Reconstruction Versus. Partial Repair for Irreparable Rotator Cuff Tears
|
N/A |